Nutritional priorities to support GLP-1 therapy for obesity: A Joint Statement
Obesity
May 2025
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT)
American Heart Journal
Volume 229, November 2020, Pages 61-69
Position Statement to Patients on Compounded GLP-1 Alternatives
OMA, TOS, and OAC Joint Statement 2024
Obesity Definition, Diagnosis, Bias, Standard Operating Procedures (SOPs), and Telehealth
An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
Obesity History, Physical Exam, Laboratory, Body Composition, and Energy Expenditure
An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
AACE/ACE Comprehensive Clinical Practice Guidelines for Medical Care of Patients With Obesity (PDF)
AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society 2013 (PDF)
Perioperative Nutrition, Metabolic and Support of Patients Undergoing Bariatric Procedures
2019 Update: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS
Thirty Obesity Myths, Misunderstandings, and/or Oversimplifications
An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
NETWORKING EVENT:
Sixty Vines at Sand Lake
7760 West Sand Lake Road
Orlando, FL 32819
Wednesday, March 11th at 6:30pm-9:00pm